These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 8761585)

  • 1. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.
    Pépin J; Khonde N
    Trans R Soc Trop Med Hyg; 1996; 90(2):183-6. PubMed ID: 8761585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis.
    Doua F; Miezan TW; Sanon Singaro JR; Boa Yapo F; Baltz T
    Am J Trop Med Hyg; 1996 Dec; 55(6):586-8. PubMed ID: 9025682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
    Nok AJ
    Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness.
    Lejon V; Robays J; N'Siesi FX; Mumba D; Hoogstoel A; Bisser S; Reiber H; Boelaert M; Büscher P
    Clin Vaccine Immunol; 2007 Jun; 14(6):732-7. PubMed ID: 17428948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human African trypanosomiasis and normality of the cerebrospinal fluid].
    Pepin J; Milord F; Guern C
    Med Trop (Mars); 1989; 49(1):29-31. PubMed ID: 2725242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.
    Pépin J; Milord F; Khonde A; Niyonsenga T; Loko L; Mpia B
    Trans R Soc Trop Med Hyg; 1994; 88(4):447-52. PubMed ID: 7570842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African sleeping sickness.
    Hedley L; Fink D; Sparkes D; Chiodini PL
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
    [No Abstract]   [Full Text] [Related]  

  • 8. Killer coma: the evolving story of sleeping sickness treatment.
    Lancet; 2010 Jan; 375(9709):93. PubMed ID: 20109869
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of human African trypanosomiasis.
    Pépin J; Milord F
    Adv Parasitol; 1994; 33():1-47. PubMed ID: 8122565
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuro-inflammatory risk factors for treatment failure in "early second stage" sleeping sickness patients treated with pentamidine.
    Lejon V; Legros D; Savignoni A; Etchegorry MG; Mbulamberi D; Büscher P
    J Neuroimmunol; 2003 Nov; 144(1-2):132-8. PubMed ID: 14597107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):777-82. PubMed ID: 17128357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A seven days course of eflornithine for relapsing Trypanosoma brucei gambiense sleeping sickness.
    Khonde N; Pépin J; Mpia B
    Trans R Soc Trop Med Hyg; 1997; 91(2):212-3. PubMed ID: 9196773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current therapy of trypanosomiasis].
    Doua F; Boa Yapo F
    Bull Soc Pathol Exot; 1994; 87(5):337-40. PubMed ID: 7496197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-sleeping sickness drugs and cancer chemotherapy.
    Barrett SV; Barrett MP
    Parasitol Today; 2000 Jan; 16(1):7-9. PubMed ID: 10637579
    [No Abstract]   [Full Text] [Related]  

  • 17. A returning traveller with fever, facial swelling, and skin lesions.
    Richter J; Göbels S; Göbel T; Westenfeld R; Müller-Stöver I; Häussinger D
    BMJ; 2012 Mar; 344():e2092. PubMed ID: 22442353
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Rhodesian sleeping sickness in Kenya.
    Wellde BT; Chumo DA; Reardon MJ; Abinya A; Wanyama L; Dola S; Mbwabi D; Smith DH; Siongok TA
    Ann Trop Med Parasitol; 1989 Aug; 83 Suppl 1():99-109. PubMed ID: 2619399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human African trypanosomiasis in Angola: clinical observations, treatment, and use of PCR for stage determination of early stage of the disease.
    Truc P; Lando A; Penchenier L; Vatunga G; Josenando T
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):10-4. PubMed ID: 22093811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.